
KALY does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for KALY and 80,000+ other tickers.
See exactly how KALY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for KALY and 80,000+ other tickers.
Kali, Inc., which conducts business as Kali-Extracts, Inc., focuses its efforts on the research and development of cannabis-based treatments. The company aims to address a variety of medical conditions, including various illnesses, diseases, and the persistent pain that can accompany diverse diagnoses. Its offerings encompass a range of products, including pharmaceutical preparations, cannabis extracts, and general health and wellness items. The entity was formerly identified as VLOV Inc. until it adopted the name Kali, Inc. in February 2016. Kali, Inc. is headquartered in Dallas, Texas.
No recent news available.